Mylan
AbbVie signs patent licensing deal with Mylan over Humira biosimilar
AbbVie has entered patent licence agreements with Mylan for the proposed biosimilar product of its Humira (adalimumab) drug. Adalimumab is…
Mylan launches generic version of Novartis’ Exelon Patch
Mylan has launched Rivastigmine Transdermal System, a generic version of Novartis' Exelon Patch, for the treatment of patients suffering from…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox